Washington, DC 2/2/15—Thomas Bachmann, president of Bruker BioSpin, has been named president and CEO of Eppendorf, a provider of laboratory products, according to a Bruker SEC filing. Mr. Bachmann is expected to join Eppendorf as CEO no later than August 1. He will resign from Bruker in July. Mr. Bachmann joined Bruker BioSpin in August […]

Company Announcements Bruker announced on its third quarter 2014 conference call that its divestiture of certain GC and GC/MS assets (see IBO 10/15/14) and its ICP-MS (see IBO 8/15/14) business generated approximately $28 million in proceeds. As part of the CAM restructuring, Bruker is relocating GC triple-quadrupole MS manufacturing from Fremont, California, to Bremen, Germany, […]

Santa Clara, CA 11/3/14; Santa Clara, 11/20/14—Agilent Technologies has announced that beginning with the current quarter, the first quarter of its fiscal year 2015, it will report in three new divisions: the Life Sciences and Applied Markets Group (LSAG), the Diagnostics and Genomics Group (DGG), and the Agilent CrossLab Group (see IBO 9/30/14). “The organization […]

Company Announcements As part of its 2014–17 medium-term management plan, Takara Bio announced fiscal 2017 sales targets for its Research Reagents business of ¥18,708 million ($184 million) and ¥2,681 million ($26 million) for its Scientific Instruments business to make up 74% and 11% of Bioindustry segment sales, respectively. GTCR completed its acquisition of Cole-Parmer (see […]

Austin, Texas 10/15/14—Luminex has announced the retirement of President and CEO Patrick J. Balthrop. The company named Nachum “Homi” Shamir as the new president and CEO. Most recently, he served as president and CEO of Given Imaging. “Mr. Shamir brings a proven track record of global leadership and results,” stated Board Chairman Wally Loewenbaum. Mr. […]

Company Announcements For the fiscal first quarter ending June 30, Hitachi High-Technologies Science and Medical Systems (SMS) sales climbed 33% to ¥38.8 billion ($380.1 million = ¥102.09 = $1) to account for 25% of company revenues (see IBO 7/31/14). Medical product sales jumped 53%, and sales of Biotechnology and Other products grew 16% to account […]

Santa Clara, CA 9/17/14; Santa Clara, CA 9/17/14; Santa Clara, CA 9/17/14—Agilent Technologies has announced that Mike McMullen, senior vice president and president of the Chemical Analysis Group (CAG), will succeed William Sullivan as CEO on March 18, 2015. Agilent has appointed Mr. McMullen president and COO, effective immediately. “Agilent’s re-launch is the perfect time […]